Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

206 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A retrospective analysis of clinical features and treatment outcome in 21 patients with immunoglobulin M-related light-chain amyloidosis in Japan: a study from the Amyloidosis Research Committee.
Fuchida SI, Ogura M, Ishida T, Hata H, Handa H, Katoh N, Nakaseko C, Sunami K, Katayama Y, Nobata H, Oshiro K, Iida S, Sekijima Y, Naiki H, Shimazaki C. Fuchida SI, et al. Among authors: nakaseko c. Int J Hematol. 2023 Oct;118(4):443-449. doi: 10.1007/s12185-023-03647-2. Epub 2023 Jul 29. Int J Hematol. 2023. PMID: 37515656
Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia.
Atsuta Y, Suzuki R, Nagamura-Inoue T, Taniguchi S, Takahashi S, Kai S, Sakamaki H, Kouzai Y, Kasai M, Fukuda T, Azuma H, Takanashi M, Okamoto S, Tsuchida M, Kawa K, Morishima Y, Kodera Y, Kato S; Japan Cord Blood Bank Network. Atsuta Y, et al. Blood. 2009 Feb 19;113(8):1631-8. doi: 10.1182/blood-2008-03-147041. Epub 2008 Dec 22. Blood. 2009. PMID: 19104080 Free article. Clinical Trial.
Clinical impact of airflow obstruction after allogeneic hematopoietic stem cell transplantation.
Nakao S, Tsukamoto S, Takeda Y, Ohwada C, Ri C, Izumi S, Kamata Y, Matsui S, Shibamiya A, Ishii A, Takaishi K, Takahashi K, Shiko Y, Oshima-Hasegawa N, Muto T, Mimura N, Yokote K, Nakaseko C, Sakaida E. Nakao S, et al. Among authors: nakaseko c. Int J Hematol. 2024 Oct;120(4):501-511. doi: 10.1007/s12185-024-03831-y. Epub 2024 Aug 27. Int J Hematol. 2024. PMID: 39190255 Free PMC article.
Survival impact of response within the first year in a multicenter prospective observational study of chronic GVHD in a Japanese cohort.
Ohwada C, Sakaida E, Takeda Y, Doki N, Igarashi A, Onizuka M, Toyosaki M, Tanaka M, Tachibana T, Kataoka K, Kato J, Fujisawa S, Kato S, Nakasone H, Naganuma K, Saitoh T, Shono K, Hagihara M, Saito T, Usuki K, Mori T, Nakaseko C, Okamoto S, Kanda Y. Ohwada C, et al. Among authors: nakaseko c. Int J Hematol. 2024 Sep;120(3):347-355. doi: 10.1007/s12185-024-03813-0. Epub 2024 Jul 17. Int J Hematol. 2024. PMID: 39017858
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP) therapy decreases lean body mass and appendicular skeletal muscle mass index even until one year after the final treatment in patients with B-cell non-Hodgkin lymphoma.
Nakao S, Ngayama D, Nakaseko C, Shimizu N. Nakao S, et al. Among authors: nakaseko c. J Chemother. 2024 Jul 11:1-7. doi: 10.1080/1120009X.2024.2376454. Online ahead of print. J Chemother. 2024. PMID: 38989820
Nilotinib vs dasatinib in achieving MR4.5 for de novo chronic myeloid leukemia: the randomized JALSG CML212 study.
Matsumura I, Ohtake S, Atsuta Y, Kurata M, Minami Y, Takahashi N, Nakaseko C, Iriyama N, Fujimaki K, Kakihana K, Ogasawara Y, Ono T, Okada M, Tauchi T, Miyamoto T, Ohnishi K, Sakaida E, Fujisawa S, Kobayashi Y, Asou N, Naoe T, Kiyoi H, Miyazaki Y. Matsumura I, et al. Among authors: nakaseko c. Blood Adv. 2024 Oct 22;8(20):5237-5247. doi: 10.1182/bloodadvances.2024012655. Blood Adv. 2024. PMID: 38968156 Free PMC article. Clinical Trial.
Detection of clonal plasma cells in POEMS syndrome using multiparameter flow cytometry.
Ishii A, Tsukamoto S, Mimura N, Miyamoto-Nagai Y, Isshiki Y, Matsui S, Nakao S, Shibamiya A, Hino Y, Kayamori K, Oshima-Hasegawa N, Muto T, Takeda Y, Suichi T, Misawa S, Ohwada C, Yokote K, Kuwabara S, Nakaseko C, Takamatsu H, Sakaida E. Ishii A, et al. Among authors: nakaseko c. Sci Rep. 2024 May 6;14(1):10362. doi: 10.1038/s41598-024-61034-1. Sci Rep. 2024. PMID: 38710832 Free PMC article.
Treatment strategy at the decision for allogeneic transplantation in patients with myelodysplastic syndrome in the era of azacitidine: A KSGCT prospective study.
Kako S, Kimura SI, Wada H, Komiya Y, Nakasone H, Sakurai M, Kato J, Tanaka M, Fujii E, Tachibana T, Yamamoto W, Hagihara M, Watanabe R, Yokota A, Nakano H, Mori T, Nakaseko C, Kanamori H, Okamoto S, Kanda Y. Kako S, et al. Among authors: nakaseko c. Leuk Res. 2023 Oct;133:107371. doi: 10.1016/j.leukres.2023.107371. Epub 2023 Aug 7. Leuk Res. 2023. PMID: 37595372
206 results